Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bockmayr

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Acta Neuropathologica|December 17, 2020
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient casesDörthe Holdhof, Pascal D Johann, Michael Spohn, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Cancer Gene Therapy|June 8, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemiaLiliana H Mochmann, Denise Treue, Michael Bockmayr, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Acta Neuropathologica|September 14, 2020
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entityLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica|December 17, 2020
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient casesDörthe Holdhof, Pascal D Johann, Michael Spohn, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Cancer Gene Therapy|June 8, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemiaLiliana H Mochmann, Denise Treue, Michael Bockmayr, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Acta Neuropathologica|September 14, 2020
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entityLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Pageof 6